Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Airway Remodeling | 1 | 2025 | 63 | 0.900 |
Why?
|
| Dermatology | 3 | 2021 | 131 | 0.880 |
Why?
|
| Murine hepatitis virus | 1 | 2024 | 16 | 0.830 |
Why?
|
| Endoribonucleases | 1 | 2024 | 77 | 0.800 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2024 | 118 | 0.780 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2025 | 411 | 0.730 |
Why?
|
| Pulmonary Fibrosis | 2 | 2025 | 395 | 0.730 |
Why?
|
| Panniculitis | 1 | 2021 | 3 | 0.670 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 3 | 2026 | 45 | 0.650 |
Why?
|
| Alveolar Epithelial Cells | 5 | 2025 | 121 | 0.640 |
Why?
|
| Homeostasis | 1 | 2024 | 644 | 0.620 |
Why?
|
| Vascular Malformations | 2 | 2018 | 52 | 0.610 |
Why?
|
| Glomus Tumor | 1 | 2017 | 2 | 0.520 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2017 | 9 | 0.520 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 22 | 0.510 |
Why?
|
| Cryopyrin-Associated Periodic Syndromes | 1 | 2016 | 6 | 0.500 |
Why?
|
| Lung | 4 | 2025 | 4116 | 0.480 |
Why?
|
| Psoriasis | 1 | 2016 | 115 | 0.450 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 166 | 0.450 |
Why?
|
| Inflammasomes | 1 | 2016 | 144 | 0.440 |
Why?
|
| Laser Therapy | 1 | 2017 | 144 | 0.440 |
Why?
|
| Telemedicine | 2 | 2021 | 967 | 0.440 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2025 | 692 | 0.360 |
Why?
|
| Amphiregulin | 1 | 2025 | 27 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4568 | 0.230 |
Why?
|
| Mice | 9 | 2026 | 18358 | 0.230 |
Why?
|
| Osteopontin | 1 | 2025 | 35 | 0.230 |
Why?
|
| Forkhead Transcription Factors | 1 | 2025 | 209 | 0.210 |
Why?
|
| eIF-2 Kinase | 1 | 2024 | 28 | 0.210 |
Why?
|
| Unfolded Protein Response | 1 | 2024 | 58 | 0.200 |
Why?
|
| Dinoprost | 1 | 2023 | 51 | 0.200 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2025 | 192 | 0.200 |
Why?
|
| Pulmonary Surfactants | 1 | 2024 | 105 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2025 | 273 | 0.200 |
Why?
|
| Animals | 10 | 2026 | 38106 | 0.170 |
Why?
|
| Mutation | 4 | 2026 | 4090 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2021 | 117 | 0.160 |
Why?
|
| Respiratory Insufficiency | 1 | 2024 | 327 | 0.160 |
Why?
|
| Mice, Transgenic | 1 | 2025 | 2192 | 0.160 |
Why?
|
| Abdomen | 1 | 2021 | 142 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2021 | 335 | 0.150 |
Why?
|
| Humans | 15 | 2026 | 145785 | 0.140 |
Why?
|
| Appointments and Schedules | 1 | 2019 | 96 | 0.140 |
Why?
|
| Autophagy | 1 | 2021 | 291 | 0.140 |
Why?
|
| Skin Diseases | 1 | 2020 | 152 | 0.140 |
Why?
|
| Dermatitis, Atopic | 1 | 2022 | 322 | 0.140 |
Why?
|
| Neutrophils | 1 | 2024 | 1127 | 0.140 |
Why?
|
| Irritants | 1 | 2018 | 42 | 0.140 |
Why?
|
| Cells, Cultured | 1 | 2025 | 4151 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2024 | 517 | 0.130 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2018 | 70 | 0.130 |
Why?
|
| Lung Injury | 1 | 2021 | 249 | 0.130 |
Why?
|
| Cytokines | 1 | 2025 | 2069 | 0.130 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2018 | 73 | 0.130 |
Why?
|
| Waiting Lists | 1 | 2019 | 266 | 0.130 |
Why?
|
| ras Proteins | 1 | 2018 | 150 | 0.130 |
Why?
|
| Sweet Syndrome | 1 | 2016 | 10 | 0.120 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 269 | 0.120 |
Why?
|
| Acne Vulgaris | 1 | 2016 | 25 | 0.120 |
Why?
|
| Eczema | 1 | 2016 | 66 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 308 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2022 | 992 | 0.110 |
Why?
|
| Pain | 1 | 2021 | 791 | 0.110 |
Why?
|
| Alleles | 1 | 2018 | 896 | 0.110 |
Why?
|
| Child | 5 | 2021 | 22740 | 0.100 |
Why?
|
| Pandemics | 1 | 2021 | 1711 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17330 | 0.090 |
Why?
|
| Adolescent | 4 | 2021 | 22577 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2601 | 0.090 |
Why?
|
| Pediatrics | 1 | 2019 | 1125 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2016 | 835 | 0.080 |
Why?
|
| Infant | 3 | 2022 | 10091 | 0.080 |
Why?
|
| Phenotype | 1 | 2018 | 3170 | 0.070 |
Why?
|
| Male | 5 | 2022 | 73012 | 0.060 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2024 | 10 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2026 | 399 | 0.050 |
Why?
|
| Protein Transport | 1 | 2026 | 442 | 0.050 |
Why?
|
| Nanomedicine | 1 | 2024 | 47 | 0.050 |
Why?
|
| Endothelium | 1 | 2024 | 119 | 0.050 |
Why?
|
| Glycolysis | 1 | 2025 | 340 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2026 | 473 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2023 | 142 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2017 | 11868 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2022 | 207 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 561 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 302 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2021 | 302 | 0.040 |
Why?
|
| Cell Line | 1 | 2026 | 2823 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 107 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2023 | 387 | 0.040 |
Why?
|
| Philadelphia | 1 | 2019 | 55 | 0.040 |
Why?
|
| Play and Playthings | 1 | 2018 | 35 | 0.030 |
Why?
|
| Mitochondria | 1 | 2025 | 994 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2023 | 1028 | 0.030 |
Why?
|
| Female | 4 | 2020 | 79045 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 104 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 1042 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 554 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 1115 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 741 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1036 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2865 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1898 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2022 | 2933 | 0.020 |
Why?
|
| Skin | 1 | 2018 | 754 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 532 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 5995 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2025 | 5226 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 1101 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 6033 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 8078 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2022 | 11794 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 40882 | 0.010 |
Why?
|